Signaling through death receptors in cancer therapy

Current Opinion in Pharmacology
Simone Fulda, Klaus-Michael Debatin

Abstract

Apoptosis--the cell's intrinsic program for death--plays a central role in regulation of tissue homeostasis. Accordingly, tipping the balance between cell death and proliferation in favor of cell survival can result in tumor formation. Also, killing of cancer cells by cytotoxic therapies (e.g. chemotherapy, gamma-irradiation, immunotherapy or suicide gene therapy) largely depends on intact apoptosis programs in cancer cells. To this end, it is implied that death receptor signaling contributes to the efficacy of cancer therapy. Failure to undergo apoptosis in response to anticancer therapy can therefore result in resistance. Thus, insights into the mechanisms regulating apoptosis in response to anticancer therapy and the ways in which cancer cells evade apoptosis might provide new opportunities for drug development.

Citations

Mar 19, 2009·Medical Molecular Morphology·Zhong-Lian LiYoshinori Otsuki
Jan 13, 2012·Cell Death & Disease·P SalomoniD Michod
Feb 24, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Johanna M NiersBakhos A Tannous
Aug 11, 2005·Oncogene·Amanda J BaxendaleAristides G Eliopoulos
Jan 13, 2006·Immunology and Cell Biology·Erika CretneyThomas J Sayers
May 9, 2012·International Journal of Hepatology·Jayashree Bagchi ChakrabortyMeagan J Walsh
Feb 9, 2011·Biochemical Pharmacology·Alfonso Garcia-BennettBengt Fadeel
Dec 28, 2010·International Immunopharmacology·Vivek R YadavBharat B Aggarwal
Oct 18, 2005·Current Opinion in Cell Biology·Sun-Mi ParkMarcus E Peter
Oct 21, 2016·Iranian Journal of Cancer Prevention·Marie JazzaraHossam Murad
Aug 13, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Angels Sierra
Nov 5, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Runlan LuoZeyao Tang
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric K Rowinsky
May 24, 2005·Biochimica Et Biophysica Acta·Marcus E PeterBryan C Barnhart
Nov 2, 2005·The Journal of Pathology·R KimK Arihiro
Dec 20, 2005·Journal of Cancer Research and Clinical Oncology·Nagathihalli S NagarajWolfgang Zacharias
May 11, 2017·Applied Biochemistry and Biotechnology·Hui-Hui YangXiu-Zhen Wang
Feb 9, 2011·Journal of Cellular Physiology·Solomon V YapAikaterini Kontrogianni-Konstantopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Biochimica Et Biophysica Acta
Simone Fulda, Klaus-Michael Debatin
Oncogene
Klaus-Michael Debatin, Peter H Krammer
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Cristina BlázquezManuel Guzmán
Annual Review of Cell and Developmental Biology
Nieng Yan, Yigong Shi
© 2022 Meta ULC. All rights reserved